{"id":"W3162603367","doi":"10.3390/curroncol28030164","title":"Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study)","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"FOLFIRI; FOLFOX; FOLFIRINOX; Medicine; Irinotecan; Oxaliplatin; Internal medicine; Gemcitabine; Oncology; Pancreatic cancer; Neutropenia; Chemotherapy; Colorectal cancer; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002282531,0.0008524875,0.001459228,0.000312073,0.0003575527,0.0006907501,0.0007950758,0.0009959546,0.001536478],"category_scores_gemma":[0.001227834,0.0003747849,0.0008956203,0.0002537082,0.0005844569,0.0004178619,0.000305149,0.002000638,0.0002941007],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001433986,"about_ca_system_score_gemma":0.001724693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002511975,"about_ca_topic_score_gemma":0.006754759,"domain_scores_codex":[0.999415,0.0003609873,0.00003139886,0.00007202855,0.00006542369,0.00005510273],"domain_scores_gemma":[0.9986354,0.0002094159,0.0003659187,0.0001287657,0.0001212841,0.0005392043],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7613552,0.04859834,0.03772637,0.0007294075,0.001875187,0.0001994548,0.0003286503,0.001938662,0.03370198,0.0002253513,0.003500729,0.1098208],"study_design_scores_gemma":[0.43016,0.4811079,0.06631076,0.0001112074,0.001726496,0.0009485421,0.00010096,0.001979481,0.01006065,0.0001819552,0.00725704,0.00005504294],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955036,0.002202302,0.0001988875,0.0002602327,0.00006549725,0.0004636318,0.0004257788,0.00002421663,0.0008558368],"genre_scores_gemma":[0.994527,0.001320768,0.00080647,0.000387958,0.000124326,0.00054295,0.001429762,0.00001580995,0.0008448626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002511975,"threshold_uncertainty_score":0.01207131,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1943415481593301,"score_gpt":0.4959062792856259,"score_spread":0.3015647311262958,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}